The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Major > G.D. Searle & Co.

G.D. Searle & Co.
 PROFILE
G.D. Searle has been filling apothecary shelves for more than a century. Its star product is arthritis treatment Celebrex, which broke prescription records in the six months after its 1999 release. Other drugs include Calan, a treatment for angina; Aldactone, for edema (swelling); and insomnia drug Ambien. It also has several drugs for women's health, including an oral contraceptive and a nasal spray for treatment of endometriosis (Synarel). Searle's pipeline includes collaborations with such firms as Chiron, Sankyo, and Synthelabo. Searle was controlled by its founding family from 1888 until 1985, when it was bought by Monsanto; it became a subsidiary of Pharmacia in the 1999 Monsanto-Pharmacia & Upjohn merger.

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 3,920.00
1-Yr. Sales Growth: 35.2%
Employees: 9,400
Revenue per employee: $417,021.28

 KEY PEOPLE
• Alan L. Heller
    CEO

 CONTACT INFO
5200 Old Orchard Rd.
Skokie, IL 60077
US
Phone: 847-982-7000
Fax: 847-470-1480
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001